New ATCvet 5th levels 2024
Updates included in the ATCvet Index valid from 2024.
| ATCvet code | ATCvet level name |
|---|---|
| QC09BX07 | zofenopril and nebivolol |
| QL04AJ06 | zilucoplan |
| QA02BD17 | vonoprazan and amoxicillin |
| QG04BD15 | vibegron |
| QH02AB18 | vamorolone |
| QB02BD15 | valoctocogene roxaparvovec |
| QA05AA05 | ursodoxicoltaurine |
| QN07XX23 | troriluzole |
| QL01FF13 | toripalimab |
| QN07XX22 | tofersen |
| QA10XX01 | teplizumab |
| QL01FX24 | teclistamab |
| QV09IA10 | technetium (99mTc) trofolastat chloride |
| QD05AX07 | tapinarof |
| QL01FX29 | talquetamab |
| QL01XL09 | tabelecleucel |
| QN02CC51 | sumatriptan and naproxen |
| QL01FF11 | sugemalimab |
| QJ05AR28 | stavudine and lamivudine |
| QB05XA20 2) | sodium selenite |
| QG04BX17 | sodium salicylate and methenamine |
| QN07XX19 | sodium phenylbutyrate and ursodoxicoltaurine |
| QI07AM04 | snake venom antiserum |
| QL01EX26 | sitravatinib |
| QA10BD29 | sitagliptin and dapagliflozin |
| QL01FF12 | serplulimab |
| QL03AB17 | sampeginterferon beta-1a |
| QR03AK15 | salbutamol and budesonide |
| QL04AG16 | rozanolixizumab |
| QC10BX20 | rosuvastatin and telmisartan |
| QC10BX21 | rosuvastatin and perindopril |
| QD05AX06 | roflumilast |
| QB01AF51 | rivaroxaban and acetylsalicylic acid |
| QL04AF08 | ritlecitinib |
| QJ05AP13 | ravidasvir |
| QL01FY03 | prolgolimab and nurulimab |
| QV03AB54 | pralidoxime and atropine |
| QI09AL09 | porcine rotavirus + escherichia + clostridium |
| QM09AX91 | polyacrylamide |
| QS01AX24 | polihexanide |
| QL01EL05 | pirtobrutinib |
| QC05AX06 | phenylephrine |
| QC09BX06 | perindopril, bisoprolol, amlodipine and indapamide |
| QN02AD51 | pentazocine and naloxone |
| QC10AB12 | pemafibrate |
| QS01XA31 | pegcetacoplan |
| QH05AA05 | palopegteriparatide |
| QA16AB27 | pabinafusp alfa |
| QL01EL04 | orelabrutinib |
| QA02BC51 | omeprazole, combinations |
| QC01CX10 | omecamtiv mecarbil |
| QL01XK52 | niraparib and abiraterone |
| QD11AH12 | nemolizumab |
| QL01XX78 | navitoclax |
| QM01AE57 | naproxen and diphenhydramine |
| QL01XL10 | nadofaragene firadenovec |
| QL01FX25 | mosunetuzumab |
| QI10AB05 | moritella |
| QL01EJ04 | momelotinib |
| QL01FX26 | mirvetuximab soravtansine |
| QL04AC24 | mirikizumab |
| QA10BD28 | metformin and teneligliptin |
| QG03DB91 | melengestrol |
| QN02BA67 | magnesium salicylate, combinations excl. psycholeptics |
| QS01CA12 | loteprednol and antiinfectives |
| QV04CX11 | lithium chloride |
| QL01XL08 | lisocabtagene maraleucel |
| QB01AC28 | limaprost |
| QL01XL11 | lifileucel |
| QL04AC25 | levilimab |
| QA16AX23 | leriglitazone |
| QL03AX22 | leniolisib |
| QN06DX04 | lecanemab |
| QD11AH10 | lebrikizumab |
| QA02BX16 | irsogladine |
| QL04AJ08 | iptacopan |
| QA10AE07 | insulin icodec |
| QL01XX80 | imetelstat |
| QD11AH92 | ilunocitinib |
| QN02AJ22 | hydrocodone and paracetamol |
| QN02AJ23 | hydrocodone and ibuprofen |
| QL01FX28 | glofitamab |
| QM09AX14 | givinostat |
| QL04AA90 | fuzapladib |
| QL01EK04 | fruquintinib |
| QB06AX05 | exagamglogene autotemcel |
| QH05BX06 | evocalcet |
| QL04AE05 | etrasimod |
| QB02BD16 | etranacogene dezaparvovec |
| QA07FA03 | escherichia coli |
| QN07XX21 | eplontersen |
| QL01FX27 | epcoritamab |
| QJ05AE16 | ensitrelvir |
| QA05AX06 | elafibranor |
| QA16AB26 | eladocagene exuparvovec |
| QL02BA04 | elacestrant |
| QL01XX79 | eflornithine |
| QL03AA19 | eflapegrastim |
| QN06DX05 | donanemab |
| QL04AG15 | divozilimab |
| QS01BA16 | difluprednate |
| QD11AH11 | delgocitinib |
| QM09AX15 | delandistrogene moxeparvovec |
| QL01BC58 | decitabine, combinations |
| QN05CJ03 | daridorexant |
| QL04AJ09 | danicopan |
| QL04AJ07 | crovalimab |
| QB02BX10 | concizumab |
| QM04AC51 | colchicine and probenecid |
| QC04AX33 | clazosentan |
| QL04AG90 | cirevetmab |
| QS01HA08 | chloroprocaine |
| QA01AB53 | chlorhexidine and cetylpyridinium |
| QC01CA28 | centhaquine |
| QJ01DC52 | cefuroxime and beta-lactamase inhibitor |
| QJ01DD58 | cefixime and beta-lactamase inhibitor |
| QJ01DE51 | cefepime and beta-lactamase inhibitor |
| QL01EX27 | capivasertib |
| QM09AX92 | canine stem cells |
| QB05XA19 1) | calcium gluconate |
| QN06AX62 | bupropion and dextromethorphan |
| QA10BK08 | bexagliflozin |
| QD03AX16 | beremagene geperpavec |
| QC05XX90 | beraprost |
| QC05XX01 | beperminogene perplasmid |
| QS01AA32 | bacitracin |
| QD11AH93 | atinvicitinib |
| QC02KN01 | aprocitentan |
| QB01AD13 | apadamtase alfa and cinaxadamtase alfa |
| QL02BX53 | abiraterone and prednisolone |
1) Parenteral formulations should be classified here. Oral preparations should be classified in QA12AA03.
2) Parenteral formulations should be classified here. Oral preparations should be classified in QA12CE02.
2) Parenteral formulations should be classified here. Oral preparations should be classified in QA12CE02.
Last updated: 2023-12-21